FINWIRES · TerminalLIVE
FINWIRES

Lupin Launches New Neuro-Rehabilitation Center in New Delhi, India

By

Pharmaceutical company Lupin (NSE:LUPIN, BOM:500257) launched a new neuro-rehabilitation center in New Delhi, India, named Atharv Ability, according to a Friday filing to the Indian stock exchanges.

The new center will offer specialized and multidisciplinary care for adults and children with neurological disabilities, including stroke, traumatic brain injury, spinal cord injury, Parkinson's disease, multiple sclerosis, and pediatric neurological disorders such as cerebral palsy.

The company had earlier opened Atharv Ability centers in Mumbai in 2023 and Hyderabad in 2024.

Lupin's shares were up nearly 1% in recent trade.

Related Articles

Asia

US, China to Discuss AI Safety Protocol, Bessent Says

The U.S. and China will discuss procedures to prevent artificial intelligence models from being acquired by non-state actors, Treasury Secretary Scott Bessent said in an interview on CNBC Friday morning in Beijing."So the two AI superpowers are going to start talking. We're going to set up a protocol in terms of, how do we go forward with best practices for AI to make sure non-state actors, don't get a hold of these models," Bessent said.Bessent did not provide a definitive timeline for the upcoming talks.Xi and Trump were expected to discuss AI during their summit in Beijing this week.

$^SSEC$^SZSE
Asia

United Spirits Names Chief Strategy Officer; Shares Up 4%

Liquor manufacturer United Spirits (NSE:MCDOWELL-N, BOM:532432) has appointed Amitabh Pande as chief strategy officer of the company, with effect from June 1, according to a Friday filing to the Indian stock exchanges.The company's shares were up nearly 4% in recent trade.Pande has 27 years of experience and has been with Diageo India since 2021, leading consumer planning, strategy, and digital transformation.

$BOM:532432$NSE:MCDOWELL-N
Asia

Jefferies Adjusts JD Logistics' Price Target to HK$20 from HK$18, Keeps at Buy

JD Logistics (HKG:2618) has an average rating of buy and mean price target of HK$18.55, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$HKG:2618